Abstract
Purpose
We retrospectively studied the different strategies of para-aortic (PA) staging of patients with PA involvement in locally advanced cervical cancer as conducted in eight centers in France and their impact upon survival and management.
Methods
All patients enrolled in this multicenter study presented with cervical cancer with PA involvement. The diagnosis of PA spread was based on imaging assessment of the PA area and/or pathological examination of harvested PA lymph nodes when staging lymphadenectomy was performed. Imaging modalities comprised positron emission tomography (PET), magnetic resonance imaging and/or computed tomography. Survival outcomes were evaluated retrospectively.
Results
One hundred and fifteen women were retrospectively studied. Radiological staging was conducted in 101 (87.8 %) patients. PET was performed in 66 patients (57.4 %). Its FN rate was 22.7 % (15/66) and its sensitivity 77.3 %. Para-aortic lymphadenectomy was conducted in a large proportion of patients (67.8 %). Its indications were not restricted to negative radiological workup. The lymphadenectomy rate was significantly higher in patients with earlier stages (p = 0.02) and lower tumor volume (p = 0.01). Treatment consisted of chemoradiation therapy with extended-field radiotherapy in all patients, followed by intracavitary brachytherapy in 94 cases (81.7 %) and completion surgery in 69 cases (60 %). Patients without para-aortic metastasis on radiological examination were more likely to receive all treatment modalities (p = 0.04).
Conclusion
Despite established recommendations, our results point out the tremendous heterogeneity regarding para-aortic assessment. These differences in management are perhaps related to a recommended therapeutic strategy that does not appear to improve the poor prognosis associated with PA involvement.
Similar content being viewed by others
References
Bonardel G, Chargari C, Gontier E, Bauduceau O, Soret M, Dechaud C, Fayolle M, Foehrenbach H (2009) Positron emission tomography in the management of cervix cancer patients. Cancer Radiother 13(6–7):490–498. doi:10.1016/j.canrad.2009.06.016
Boughanim M, Leboulleux S, Rey A, Pham CT, Zafrani Y, Duvillard P, Lumbroso J, Haie-Meder C, Schlumberger M, Morice P (2008) Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol Off J Am Soc Clin Oncol 26(15):2558–2561. doi:10.1200/JCO.2007.14.3933
Brockbank E, Kokka F, Bryant A, Pomel C, Reynolds K (2013) Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. The Cochrane database of systematic reviews 3:CD008217. doi:10.1002/14651858.CD008217.pub3
Chantalat E, Vidal F, Leguevaque P, Lepage B, Mathevet P, Deslandres M, Motton S (2015) Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers. Eur J Obstet Gynecol Reprod Biol 193:118–122. doi:10.1016/j.ejogrb.2015.07.017
Cui L, Shi Y, Zhang GN (2015) Perineural invasion as a prognostic factor for cervical cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 292(1):13–19. doi:10.1007/s00404-015-3627-z
Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, Macapinlac HA, Leblanc E, Martinez A, Ramirez PT (2013) Lymphadenectomy in Locally Advanced Cervical Cancer Study (LiLACS): a phase III clinical trial comparing surgical to radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. doi:10.1016/j.jmig.2013.07.007
Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R (2008) Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer 112(9):1954–1963. doi:10.1002/cncr.23400
Gouy S, Morice P, Narducci F, Uzan C, Gilmore J, Kolesnikov-Gauthier H, Querleu D, Haie-Meder C, Leblanc E (2012) Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol 13(5):e212–e220. doi:10.1016/S1470-2045(12)70011-6
Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, Bentivegna E, Pautier P, Deandreis D, Querleu D, Haie-Meder C, Leblanc E (2013) Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol Off J Am Soc Clin Oncol 31(24):3026–3033. doi:10.1200/JCO.2012.47.3520
Gouy S, Uzan C, Scherier S, Gauthier T, Bentivegna E, Kane A, Morice P, Marchal F (2014) Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients. Surg Endosc 28(1):249–256. doi:10.1007/s00464-013-3180-4
Haie-Meder C, Mazeron R, Magne N (2010) Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers. Radiother Oncol J Eur Soc Ther Radiol Oncol 96(3):351–355. doi:10.1016/j.radonc.2010.07.010
Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER (2005) FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97(1):183–191. doi:10.1016/j.ygyno.2004.12.007
Institut National du Cancer H (2010) Cancer invasif du col utérin, État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France
Kavallaris A, Kalogiannidis I, Chalvatzas N, Hornemann A, Bohlmann MK, Diedrich K (2011) Standardized technique of laparoscopic pelvic and para-aortic lymphadenectomy in gynecologic cancer optimizes the perioperative outcomes. Arch Gynecol Obstet 283(6):1373–1380. doi:10.1007/s00404-010-1580-4
Leblanc E, Narducci F, Frumovitz M, Lesoin A, Castelain B, Baranzelli MC, Taieb S, Fournier C, Querleu D (2007) Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol 105(2):304–311. doi:10.1016/j.ygyno.2006.12.012
Lv X, Chen L, Yu H, Zhang X, Yan D (2012) Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer. Arch Gynecol Obstet 285(3):811–816. doi:10.1007/s00404-011-2038-z
Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P (1998) Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 91(3):360–363
Paumier A, Blanchard P, Mazeron R, Dumas I, Morice P, Lhomme C, Leboulleux S, Haie-Meder C (2012) Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET. Cancer Radiother 16(3):183–189. doi:10.1016/j.canrad.2011.11.005
Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol obstet Off Org Int Fed Gynaecol Obstet 105(2):103–104
Richard SD, Krivak TC, Castleberry A, Beriwal S, Kelley JL 3rd, Edwards RP, Sukumvanich P (2008) Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. Gynecol Oncol 109(1):43–48. doi:10.1016/j.ygyno.2007.12.002
Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, Cooper J, John M (1995) Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79–20. JAMA J Am Med Assoc 274(5):387–393
Scandurra G, Scibilia G, Banna GL, D’Agate G, Lipari H, Gieri S, Scollo P (2015) Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma. J Gynecol Oncol 26(2):118–124. doi:10.3802/jgo.2015.26.2.118
Scheidler J, Hricak H, Yu KK, Subak L, Segal MR (1997) Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA J Am Med Assoc 278(13):1096–1101
Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K (2008) Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 178(7):855–862. doi:10.1503/cmaj.071124
Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC (1991) Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67(11):2776–2785
Uzan C, Gouy S, Pautier P, Haie-Meder C, Duvillard P, Narducci F, Leblanc E, Morice P (2010) Para-aortic lymphadenectomy in advanced-stage cervical cancer: standard procedure in 2010? Gynecol Obstet Fertil 38(11):668–671. doi:10.1016/j.gyobfe.2010.08.019
Varia MA, Bundy BN, Deppe G, Mannel R, Averette HE, Rose PG, Connelly P (1998) Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42(5):1015–1023
Acknowledgments
We would like to thank P Mathevet (Suisse), Xavier Montbarbon (Lyon), M Deslandres (Toulouse), Yves Aubard (Limoges), Vanessa Conri (Bordeaux), Jean-Marc Classe, Isabelle Jaffre, Emmanuelle Jougla (Nantes), Benedicte Groff (Strasbourg) and Nina Crowte for technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest, and they have no financial relationship with the organization that sponsored the research.
Rights and permissions
About this article
Cite this article
Chantalat, E., Vidal, F., Leguevaque, P. et al. Para-aortic workup in locally advanced cervical cancer: heterogeneity is still the rule. Results from a retrospective multicenter study. Arch Gynecol Obstet 293, 1081–1086 (2016). https://doi.org/10.1007/s00404-015-3885-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3885-9